Medtronic PLC (MDT)
84.74
+0.63
(+0.75%)
USD |
NYSE |
Nov 21, 16:00
84.76
+0.02
(+0.02%)
Pre-Market: 08:18
Medtronic Revenue (Quarterly): 8.403B for Oct. 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2024 | 8.403B |
| July 31, 2024 | 7.915B |
| April 30, 2024 | 8.589B |
| January 31, 2024 | 8.089B |
| October 31, 2023 | 7.984B |
| July 31, 2023 | 7.702B |
| April 30, 2023 | 8.545B |
| January 31, 2023 | 7.727B |
| October 31, 2022 | 7.585B |
| July 31, 2022 | 7.371B |
| April 30, 2022 | 8.089B |
| January 31, 2022 | 7.763B |
| October 31, 2021 | 7.847B |
| July 31, 2021 | 7.987B |
| April 30, 2021 | 8.188B |
| January 31, 2021 | 7.775B |
| October 31, 2020 | 7.647B |
| July 31, 2020 | 6.507B |
| April 30, 2020 | 5.997B |
| January 31, 2020 | 7.717B |
| October 31, 2019 | 7.706B |
| July 31, 2019 | 7.493B |
| April 30, 2019 | 8.146B |
| January 31, 2019 | 7.546B |
| October 31, 2018 | 7.481B |
| Date | Value |
|---|---|
| July 31, 2018 | 7.384B |
| April 30, 2018 | 8.144B |
| January 31, 2018 | 7.369B |
| October 31, 2017 | 7.05B |
| July 31, 2017 | 7.39B |
| April 30, 2017 | 7.916B |
| January 31, 2017 | 7.283B |
| October 31, 2016 | 7.345B |
| July 31, 2016 | 7.166B |
| April 30, 2016 | 7.567B |
| January 31, 2016 | 6.934B |
| October 31, 2015 | 7.058B |
| July 31, 2015 | 7.274B |
| April 30, 2015 | 7.304B |
| January 31, 2015 | 4.318B |
| October 31, 2014 | 4.366B |
| July 31, 2014 | 4.273B |
| April 30, 2014 | 4.565B |
| January 31, 2014 | 4.163B |
| October 31, 2013 | 4.194B |
| July 31, 2013 | 4.083B |
| April 30, 2013 | 4.46B |
| January 31, 2013 | 4.027B |
| October 31, 2012 | 4.095B |
| July 31, 2012 | 4.008B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.997B
Minimum
Apr 2020
8.589B
Maximum
Apr 2024
7.771B
Average
7.811B
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Axonics Inc | 116.19M |
| TransMedics Group Inc | 108.76M |
| Inari Medical Inc | 153.39M |
| Agilent Technologies Inc | 1.578B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.27B |
| Total Expenses (Quarterly) | 6.779B |
| EPS Diluted (Quarterly) | 0.99 |
| Enterprise Value | 129.24B |
| Gross Profit Margin (Quarterly) | 64.94% |
| Profit Margin (Quarterly) | 15.11% |
| Earnings Yield | 3.86% |
| Operating Earnings Yield | 5.18% |
| Normalized Earnings Yield | 4.101 |